Clinical uses and control of rifampicin and clindamycin.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001439:Bacteroides / Q000187:drug effects; D003013:Clostridium / Q000187:drug effects; D013293:Enterococcus faecalis / Q000187:drug effects; D006027:Glycosides / Q000627:therapeutic use; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D009174:Mycoplasma / Q000187:drug effects; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D009345:Neisseria meningitidis / Q000187:drug effects; D011759:Pyrrolidines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D012505:Sarcina; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines; D012293:Rifampin